Deborah J. Wexler, MD, MSc, and colleagues reviewed recent shifts in diabetes care, such as SGLT2i and GLP-1 RA medications.
In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...
These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic ...
This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...
Flatulence is an entirely normal process which occurs up to 20 times a day, often the sign of a healthy gut. But there are ...
Results demonstrated that similar outcomes can be achieved by a human coach-based program and an AI-based program. Moreover, ...
News-Medical.Net on MSN
AI-powered app matches human-led programs in diabetes prevention
Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered ...
Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered ...
Everyday Health on MSN
8 Times When Vitamins and Supplements May Be Good Self-Care
Most healthy people can get enough nutrients from food, but people with certain health conditions may benefit from specific ...
Mrs. L, a 72-year-old woman with type 2 diabetes, had been taking metformin for the past 8 years to control her blood sugar. Recently, she began experiencing persistent fatigue and a tingling ...
A new study shows that women who go through menopause earlier in life may have a higher risk of developing metabolic syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback